Literature DB >> 14550555

Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300.

Bruno Fuchs1, Carrie Y Inwards, Ralf Janknecht.   

Abstract

The mechanisms of action of Ewing's sarcoma (EWS) associated EWS-ETS oncoproteins have largely remained unresolved. Here, we analyzed how two EWS-ETS proteins, EWS-ER81 and EWS-Fli-1, in vitro activate the matrix metalloproteinase (MMP)-1 promoter that is upregulated in a subset of EWSs. EWS-ER81 and EWS-Fli-1 interact with and thereby activate the MMP-1 promoter, which is potentiated by the cofactor p300 and the proto-oncoprotein c-Jun. Further, EWS-ER81 binds to c-Jun in vitro and in vivo. The interaction between c-Jun, p300 and EWS-ER81 or EWS-Fli-1 may also be relevant to the regulation of other yet-to-be-identified genes that are responsible for EWS formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550555     DOI: 10.1016/s0014-5793(03)00984-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Downregulation of Friend leukemia virus integration 1 as a feedback mechanism that restrains lipopolysaccharide induction of matrix metalloproteases and interleukin-10 in human macrophages.

Authors:  Hao H Ho; Lionel B Ivashkiv
Journal:  J Interferon Cytokine Res       Date:  2010-09-29       Impact factor: 2.607

2.  Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.

Authors:  Pankaj K Singh; Michelle E Behrens; John P Eggers; Ronald L Cerny; Jennifer M Bailey; Kandavel Shanmugam; Sandra J Gendler; Eric P Bennett; Michael A Hollingsworth
Journal:  J Biol Chem       Date:  2008-07-14       Impact factor: 5.157

Review 3.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

4.  A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.

Authors:  Marius S Pop; Nicolas Stransky; Colin W Garvie; Jean-Philippe Theurillat; Emily C Hartman; Timothy A Lewis; Cheng Zhong; Elizabeth K Culyba; Fallon Lin; Douglas S Daniels; Raymond Pagliarini; Lucienne Ronco; Angela N Koehler; Levi A Garraway
Journal:  Mol Cancer Ther       Date:  2014-04-15       Impact factor: 6.261

5.  Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity.

Authors:  Silke Schlottmann; Hayriye V Erkizan; Julie S Barber-Rotenberg; Chad Knights; Amrita Cheema; Aykut Uren; Maria L Avantaggiati; Jeffrey A Toretsky
Journal:  Front Oncol       Date:  2012-09-07       Impact factor: 6.244

6.  Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.

Authors:  David Herrero-Martin; Argyro Fourtouna; Stephan Niedan; Lucia T Riedmann; Raphaela Schwentner; Dave N T Aryee
Journal:  Sarcoma       Date:  2011-11-10

7.  The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription.

Authors:  Min-Kyoung Kim; Jung-Min Shin; Hee Chul Eun; Jin Ho Chung
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

8.  The induction of CCN2 by TGFbeta1 involves Ets-1.

Authors:  Jonathan P Van Beek; Laura Kennedy; Jason S Rockel; Suzanne M Bernier; Andrew Leask
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

9.  Plakophilin-3 catenin associates with the ETV1/ER81 transcription factor to positively modulate gene activity.

Authors:  William A Munoz; Moonsup Lee; Rachel K Miller; Zamal Ahmed; Hong Ji; Todd M Link; Gilbert R Lee; Malgorzata Kloc; John E Ladbury; Pierre D McCrea
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.

Authors:  Weiwen He; Yanna Wu; Xiaomei Tang; Yong Xia; Guozhen He; Zhiqun Min; Chun Li; Shiqiu Xiong; Zhi Shi; Yongjian Lu; Zhongmin Yuan
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.